Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.

Sanchez A, Furberg H, Kuo F, Vuong L, Ged Y, Patil S, Ostrovnaya I, Petruzella S, Reising A, Patel P, Mano R, Coleman J, Russo P, Liu CH, Dannenberg AJ, Chan TA, Motzer R, Voss MH, Hakimi AA.

Lancet Oncol. 2019 Dec 20. pii: S1470-2045(19)30797-1. doi: 10.1016/S1470-2045(19)30797-1. [Epub ahead of print]

PMID:
31870811
2.

Influence of Contrast Administration on Computed Tomography-Based Analysis of Visceral Adipose and Skeletal Muscle Tissue in Clear Cell Renal Cell Carcinoma.

Paris MT, Furberg HF, Petruzella S, Akin O, Hötker AM, Mourtzakis M.

JPEN J Parenter Enteral Nutr. 2018 Sep;42(7):1148-1155. doi: 10.1002/jpen.1067. Epub 2018 Jan 19.

PMID:
29350403
3.

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.

Lee BH, Zabor EC, Tennenbaum D, Furberg H, Benfante N, Coleman JA, Jaimes EA, Russo P.

World J Urol. 2018 Feb;36(2):257-263. doi: 10.1007/s00345-017-2139-9. Epub 2017 Dec 5.

4.

Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study.

Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P.

J Urol. 2018 Apr;199(4):921-926. doi: 10.1016/j.juro.2017.10.027. Epub 2017 Oct 21.

5.

Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.

Sun X, Hoadley KA, Kim WY, Furberg H, Olshan AF, Troester MA.

Cancer Causes Control. 2017 Jun;28(6):539-544. doi: 10.1007/s10552-017-0885-z. Epub 2017 Mar 20.

6.

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DYC, Choueiri TK.

J Clin Oncol. 2016 Oct 20;34(30):3655-3663. doi: 10.1200/JCO.2016.66.7311.

7.

Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Murray KS, Zabor EC, Spaliviero M, Russo P, Bazzi WM, Musser JE, Ari Hakimi A, Bernstein ML, Dalbagni G, Coleman JA, Furberg H.

World J Urol. 2016 Dec;34(12):1667-1672. Epub 2016 Apr 22.

8.

Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans.

David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang H, Kooperberg CL, Quesenberry CP, Tindle H, Patel MI, Amos CI, Bergen AW, Swan GE, Stefanick ML.

EBioMedicine. 2016 Jan 11;4:153-61. doi: 10.1016/j.ebiom.2016.01.002. eCollection 2016 Feb.

9.

Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.

Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Furberg H, Matullo G, Golka K, Gago-Dominguez M, Taylor JA, Fletcher T, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, Purdue MP, Jacobs EJ, Albanes D, Wang Z, Chung CC, Vermeulen SH, Aben KK, Galesloot TE, Thorleifsson G, Sulem P, Stefansson K, Kiltie AE, Harland M, Teo M, Offit K, Vijai J, Bajorin D, Kopp R, Fiorito G, Guarrera S, Sacerdote C, Selinski S, Hengstler JG, Gerullis H, Ovsiannikov D, Blaszkewicz M, Castelao JE, Calaza M, Martinez ME, Cordeiro P, Xu Z, Panduri V, Kumar R, Gurzau E, Koppova K, Bueno-De-Mesquita HB, Ljungberg B, Clavel-Chapelon F, Weiderpass E, Krogh V, Dorronsoro M, Travis RC, Tjønneland A, Brennan P, Chang-Claude J, Riboli E, Conti D, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Jeppson RP, Cancel-Tassin G, Roupret M, Comperat E, Turman C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Kamat AM, Zhang L, Gong Y, Pu X, Hutchinson A, Burdett L, Wheeler WA, Karagas MR, Johnson A, Schned A, Monawar Hosain GM, Schwenn M, Kogevinas M, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Andriole G Jr, Grubb R 3rd, Black A, Diver WR, Gapstur SM, Weinstein S, Virtamo J, Haiman CA, Landi MT, Caporaso NE, Fraumeni JF Jr, Vineis P, Wu X, Chanock SJ, Silverman DT, Prokunina-Olsson L, Rothman N.

Hum Mol Genet. 2016 Mar 15;25(6):1203-14. doi: 10.1093/hmg/ddv492. Epub 2016 Jan 4.

10.

The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.

Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF.

Cancer. 2016 Mar 1;122(5):712-21. doi: 10.1002/cncr.29801. Epub 2015 Nov 30.

11.

Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms.

Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):101-7. doi: 10.2215/CJN.04070415. Epub 2015 Oct 23.

12.

Genomic investigation of etiologic heterogeneity: methodologic challenges.

Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ.

BMC Med Res Methodol. 2014 Dec 22;14:138. doi: 10.1186/1471-2288-14-138.

13.

The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.

Furberg H, Schoenberg M.

Urol Oncol. 2015 Jan;33(1):49. doi: 10.1016/j.urolonc.2014.09.011. Epub 2014 Nov 6. No abstract available.

PMID:
25443266
14.

Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P.

Can Urol Assoc J. 2014 Sep;8(9-10):E675-80. doi: 10.5489/cuaj.1979.

15.

Selection bias: a missing factor in the obesity paradox debate.

Robinson WR, Furberg H, Banack HR.

Obesity (Silver Spring). 2014 Mar;22(3):625. No abstract available.

16.

Polygenic risk scores for smoking: predictors for alcohol and cannabis use?

Vink JM, Hottenga JJ, de Geus EJ, Willemsen G, Neale MC, Furberg H, Boomsma DI.

Addiction. 2014 Jul;109(7):1141-51. doi: 10.1111/add.12491. Epub 2014 Mar 18.

17.

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikklineni N, Fiegoli B, Kim PH, Voss MH, Shen H, Laird PW, Sander C, Reuter VE, Motzer RJ, Hsieh JJ, Russo P.

J Natl Cancer Inst. 2013 Dec 18;105(24):1862-70. doi: 10.1093/jnci/djt310. Epub 2013 Nov 27.

18.

Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.

Stephens SH, Hartz SM, Hoft NR, Saccone NL, Corley RC, Hewitt JK, Hopfer CJ, Breslau N, Coon H, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, Han Y, Hansel NN, Jiang C, Korhonen T, Lind PA, Liu J, Lyytikäinen LP, Michel M, Shaffer JR, Short SE, Sun J, Teumer A, Thompson JR, Vogelzangs N, Vink JM, Wenzlaff A, Wheeler W, Yang BZ, Aggen SH, Balmforth AJ, Baumeister SE, Beaty TH, Benjamin DJ, Bergen AW, Broms U, Cesarini D, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick D, Foroud T, Furberg H, Giegling I, Gillespie NA, Gu F, Hall AS, Hällfors J, Han S, Hartmann AM, Heikkilä K, Hickie IB, Hottenga JJ, Jousilahti P, Kaakinen M, Kähönen M, Koellinger PD, Kittner S, Konte B, Landi MT, Laatikainen T, Leppert M, Levy SM, Mathias RA, McNeil DW, Medland SE, Montgomery GW, Murray T, Nauck M, North KE, Paré PD, Pergadia M, Ruczinski I, Salomaa V, Viikari J, Willemsen G, Barnes KC, Boerwinkle E, Boomsma DI, Caporaso N, Edenberg HJ, Francks C, Gelernter J, Grabe HJ, Hops H, Jarvelin MR, Johannesson M, Kendler KS, Lehtimäki T, Magnusson PK, Marazita ML, Marchini J, Mitchell BD, Nöthen MM, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Schwartz AG, Shete S, Spitz M, Swan GE, Völzke H, Veijola J, Wei Q, Amos C, Cannon DS, Grucza R, Hatsukami D, Heath A, Johnson EO, Kaprio J, Madden P, Martin NG, Stevens VL, Weiss RB, Kraft P, Bierut LJ, Ehringer MA.

Genet Epidemiol. 2013 Dec;37(8):846-59. doi: 10.1002/gepi.21760. Epub 2013 Nov 1.

19.

A common biological basis of obesity and nicotine addiction.

Thorgeirsson TE, Gudbjartsson DF, Sulem P, Besenbacher S, Styrkarsdottir U, Thorleifsson G, Walters GB; TAG Consortium; Oxford-GSK Consortium; ENGAGE consortium, Furberg H, Sullivan PF, Marchini J, McCarthy MI, Steinthorsdottir V, Thorsteinsdottir U, Stefansson K.

Transl Psychiatry. 2013 Oct 1;3:e308. doi: 10.1038/tp.2013.81.

20.

Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P.

J Urol. 2014 Mar;191(3):597-602. doi: 10.1016/j.juro.2013.08.081. Epub 2013 Sep 7.

21.

Bladder cancer: Towards risk stratification in bladder cancer.

Furberg H, Bochner BH.

Nat Rev Urol. 2013 Jul;10(7):374-5. doi: 10.1038/nrurol.2013.114. Epub 2013 May 21. No abstract available.

PMID:
23689256
22.

All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs.

Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, Kelsoe JR, O'Donovan MC, Furberg H; Tobacco and Genetics Consortium; Bipolar Disorder Psychiatric Genomics Consortium; Schizophrenia Psychiatric Genomics Consortium, Schork NJ, Andreassen OA, Dale AM.

PLoS Genet. 2013 Apr;9(4):e1003449. doi: 10.1371/journal.pgen.1003449. Epub 2013 Apr 25.

23.

Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.

Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF.

Eur Urol. 2013 Sep;64(3):456-64. doi: 10.1016/j.eururo.2012.11.039. Epub 2012 Nov 27.

PMID:
23206854
24.

Initial reactions to tobacco use and risk of future regular use.

Zabor EC, Li Y, Thornton LM, Shuman MR, Bulik CM, Lichtenstein P, Pedersen NL, Sullivan PF, Furberg H.

Nicotine Tob Res. 2013 Feb;15(2):509-17. doi: 10.1093/ntr/nts180. Epub 2012 Sep 4.

25.

Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.

Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF.

Eur Urol. 2013 Apr;63(4):724-32. doi: 10.1016/j.eururo.2012.08.025. Epub 2012 Aug 21.

26.

Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.

Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH, Coon H, Han Y, Stephens SH, Sun J, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, Geller F, Gubjartsson D, Hansel NN, Jiang C, Keskitalo-Vuokko K, Liu Z, Lyytikäinen LP, Michel M, Rawal R, Rosenberger A, Scheet P, Shaffer JR, Teumer A, Thompson JR, Vink JM, Vogelzangs N, Wenzlaff AS, Wheeler W, Xiao X, Yang BZ, Aggen SH, Balmforth AJ, Baumeister SE, Beaty T, Bennett S, Bergen AW, Boyd HA, Broms U, Campbell H, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick DM, Foroud T, Furberg H, Giegling I, Gu F, Hall AS, Hällfors J, Han S, Hartmann AM, Hayward C, Heikkilä K, Hewitt JK, Hottenga JJ, Jensen MK, Jousilahti P, Kaakinen M, Kittner SJ, Konte B, Korhonen T, Landi MT, Laatikainen T, Leppert M, Levy SM, Mathias RA, McNeil DW, Medland SE, Montgomery GW, Muley T, Murray T, Nauck M, North K, Pergadia M, Polasek O, Ramos EM, Ripatti S, Risch A, Ruczinski I, Rudan I, Salomaa V, Schlessinger D, Styrkársdóttir U, Terracciano A, Uda M, Willemsen G, Wu X, Abecasis G, Barnes K, Bickeböller H, Boerwinkle E, Boomsma DI, Caporaso N, Duan J, Edenberg HJ, Francks C, Gejman PV, Gelernter J, Grabe HJ, Hops H, Jarvelin MR, Viikari J, Kähönen M, Kendler KS, Lehtimäki T, Levinson DF, Marazita ML, Marchini J, Melbye M, Mitchell BD, Murray JC, Nöthen MM, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Sanders AR, Schwartz AG, Shete S, Shi J, Spitz M, Stefansson K, Swan GE, Thorgeirsson T, Völzke H, Wei Q, Wichmann HE, Amos CI, Breslau N, Cannon DS, Ehringer M, Grucza R, Hatsukami D, Heath A, Johnson EO, Kaprio J, Madden P, Martin NG, Stevens VL, Stitzel JA, Weiss RB, Kraft P, Bierut LJ.

Arch Gen Psychiatry. 2012 Aug;69(8):854-60. doi: 10.1001/archgenpsychiatry.2012.124.

27.

Genome-wide meta-analyses of smoking behaviors in African Americans.

David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C, Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H.

Transl Psychiatry. 2012 May 22;2:e119. doi: 10.1038/tp.2012.41.

28.

Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.

Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration.

Eur Urol. 2013 Jun;63(6):1082-90. doi: 10.1016/j.eururo.2012.06.029. Epub 2012 Jun 22.

29.

Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.

Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G.

BJU Int. 2013 Apr;111(4):589-95. doi: 10.1111/j.1464-410X.2012.11260.x. Epub 2012 May 29.

30.

Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25.

Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Chen YT, Cheng YC, Cho YS, David SP, Duan J, Eaton CB, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, Rice TK, Schwantes-An TH, Shete SS, Shi J, Spitz MR, Sun YV, Tsai FJ, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu JY, Yokota J, Amos CI, Bierut LJ.

Genet Epidemiol. 2012 May;36(4):340-51. doi: 10.1002/gepi.21627. Erratum in: Genet Epidemiol. 2012 Jul;36(5):525-6.

31.

The comorbidity of self-reported chronic fatigue syndrome, post-traumatic stress disorder, and traumatic symptoms.

Dansie EJ, Heppner P, Furberg H, Goldberg J, Buchwald D, Afari N.

Psychosomatics. 2012 May-Jun;53(3):250-7. doi: 10.1016/j.psym.2011.08.007. Epub 2012 Jan 31.

32.

Conditions comorbid with chronic fatigue in a population-based sample.

Dansie EJ, Furberg H, Afari N, Buchwald D, Edwards K, Goldberg J, Schur E, Sullivan PF.

Psychosomatics. 2012 Jan-Feb;53(1):44-50. doi: 10.1016/j.psym.2011.04.001. Epub 2011 Sep 22.

33.

The public health utility of genome-wide association study results for smoking behavior.

Furberg H, Ostroff J, Lerman C, Sullivan PF.

Genome Med. 2010 Apr 27;2(4):26. doi: 10.1186/gm147.

34.

Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women.

Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M.

J Oncol. 2009;2009:871250. doi: 10.1155/2009/871250. Epub 2009 Oct 25.

35.

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases.

Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP.

Am J Epidemiol. 2009 Aug 1;170(3):269-79. doi: 10.1093/aje/kwp119. Epub 2009 Jun 4.

36.

The STAGE cohort: a prospective study of tobacco use among Swedish twins.

Furberg H, Lichtenstein P, Pedersen NL, Thornton L, Bulik CM, Lerman C, Sullivan PF.

Nicotine Tob Res. 2008 Dec;10(12):1727-35. doi: 10.1080/14622200802443551.

37.

Snus use and other correlates of smoking cessation in the Swedish Twin Registry.

Furberg H, Lichtenstein P, Pedersen NL, Bulik CM, Lerman C, Sullivan PF.

Psychol Med. 2008 Sep;38(9):1299-308. doi: 10.1017/S0033291707002346.

38.

A searchable database of genetic evidence for psychiatric disorders.

Konneker T, Barnes T, Furberg H, Losh M, Bulik CM, Sullivan PF.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):671-5. doi: 10.1002/ajmg.b.30802.

39.

A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries.

Fagerström K, Furberg H.

Addiction. 2008 May;103(5):841-5. doi: 10.1111/j.1360-0443.2008.02190.x.

40.

Is low-nicotine Marlboro snus really snus?

Foulds J, Furberg H.

Harm Reduct J. 2008 Feb 27;5:9. doi: 10.1186/1477-7517-5-9.

41.

Genomewide linkage survey of nicotine dependence phenotypes.

Sullivan PF, Kuo PH, Webb BT, Neale MC, Vittum J, Furberg H, Walsh D, Patterson DG, Riley B, Prescott CA, Kendler KS.

Drug Alcohol Depend. 2008 Mar 1;93(3):210-6. Epub 2007 Nov 19.

42.

Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions.

Schur EA, Afari N, Furberg H, Olarte M, Goldberg J, Sullivan PF, Buchwald D.

J Gen Intern Med. 2007 Jun;22(6):818-21.

43.

Cigarettes and oral snuff use in Sweden: Prevalence and transitions.

Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF.

Addiction. 2006 Oct;101(10):1509-15.

44.

Prevalence, heritability, and prospective risk factors for anorexia nervosa.

Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL.

Arch Gen Psychiatry. 2006 Mar;63(3):305-12. Erratum in: Arch Gen Psychiatry. 2008 Sep;65(9):1061.

PMID:
16520436
45.

Is Swedish snus associated with smoking initiation or smoking cessation?

Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF.

Tob Control. 2005 Dec;14(6):422-4.

46.

The prevalence of self-reported chronic fatigue in a U.S. twin registry.

Furberg H, Olarte M, Afari N, Goldberg J, Buchwald D, Sullivan PF.

J Psychosom Res. 2005 Nov;59(5):283-90.

47.

The types of regular cigarette smokers: a latent class analysis.

Furberg H, Sullivan PF, Maes H, Prescott CA, Lerman C, Bulik C, Kendler KS.

Nicotine Tob Res. 2005 Jun;7(3):351-60.

PMID:
16085503
48.

For the patient. Recruitment strategies for cancer research studies.

Gooden KM, Carter-Edwards L, Hoyo C, Akbar J, Cleveland RJ, Oates V, Jackson E, Furberg H, Gammon MD.

Ethn Dis. 2005 Winter;15(1):151. No abstract available.

PMID:
15720063
49.

Perceptions of participation in an observational epidemiologic study of cancer among African Americans.

Gooden KM, Carter-Edwards L, Hoyo C, Akbar J, Cleveland RJ, Oates V, Jackson E, Furberg H, Gammon MD.

Ethn Dis. 2005 Winter;15(1):68-75.

PMID:
15720051
50.

Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer.

Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C, Coles B, Trovato A.

Cancer Res. 2005 Feb 1;65(3):1105-11.

Supplemental Content

Loading ...
Support Center